Literature DB >> 25631041

Novel mutation in STXBP1 gene in a patient with non-lesional Ohtahara syndrome.

L Ortega-Moreno1, B G Giráldez1, A Verdú2, O García-Campos2, G Sánchez-Martín1, J M Serratosa3, R Guerrero-López1.   

Abstract

INTRODUCTION: Ohtahara syndrome (OS, OMIM#308350, ORPHA1934) is an early-onset epileptic encephalopathy (EOEE) characterised by spasms, intractable seizures, suppression-burst pattern on the electroencephalogram, and severe psychomotor retardation. Mutations in STXBP1 -a gene that codes for syntaxin binding protein 1 and is involved in synaptic vesicle exocytosis- has been identified in most patients with OS. PATIENT AND
RESULTS: We report the case of a 19-month-old child with OS who displays a previously unreported mutation in STXBP1 (c.1249+2T>C, G417AfsX7). This mutation is located in a donor splice site and eliminates exon 14, resulting in a truncated protein.
CONCLUSION: This previously unreported STXBP1 mutation in a subject with Ohtahara syndrome and non-lesional magnetic resonance imaging (MRI) broadens the mutational spectrum associated with this devastating epileptic syndrome.
Copyright © 2014 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Clinical genetics; Early-onset epileptic encephalopathy; Encefalopatía epiléptica de inicio precoz; Epilepsia; Epilepsy; Genética clínica; Ohtahara syndrome; STXBP1; Síndrome de Ohtahara

Mesh:

Substances:

Year:  2015        PMID: 25631041     DOI: 10.1016/j.nrl.2014.10.017

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  2 in total

1.  Role of Munc18-1 in the biological functions and pathogenesis of neurological disorders (Review).

Authors:  Fajuan Tang; Dongqiong Xiao; Lin Chen; Hu Gao; Xihong Li
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

Review 2.  Epileptic Phenotypes Associated With SNAREs and Related Synaptic Vesicle Exocytosis Machinery.

Authors:  Elisa Cali; Clarissa Rocca; Vincenzo Salpietro; Henry Houlden
Journal:  Front Neurol       Date:  2022-01-13       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.